Karyopharm Therapeutics
KPTI
#9451
Rank
$55.26 M
Marketcap
$6.07
Share price
8.01%
Change (1 day)
451.82%
Change (1 year)

P/S ratio for Karyopharm Therapeutics (KPTI)

P/S ratio as of April 2025 (TTM): 0.3805

According to Karyopharm Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -0.2971. At the end of 2024 the company had a P/S ratio of 0.6091.

P/S ratio history for Karyopharm Therapeutics from 2013 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20240.6091-10.22%
20230.6784-72.32%
20222.455.85%
20212.32-78.04%
202010.5-65.6%
201930.663.1%
201818.8-93.34%
2017282-88.79%
2016> 100032.44%
2015> 1000-64.59%
2014> 1000206.35%
2013> 1000

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
3.26 757.41%๐Ÿ‡บ๐Ÿ‡ธ USA
2.10 453.09%๐Ÿ‡บ๐Ÿ‡ธ USA
5.38 1,313.23%๐Ÿ‡บ๐Ÿ‡ธ USA
4.88 1,183.80%๐Ÿ‡บ๐Ÿ‡ธ USA